Concepedia

Maurizio Rainisio

MR

Statistics

Publications

29

Citations

6.3K

H-Index

24

Active since

1983

Affiliations

Actelion (Switzerland)(Current)

Duke Medical Center

University of California, San Francisco

San Francisco VA Medical Center

Ospedale di Sanremo

Maurizio Rainisio is an author at Actelion (Switzerland) specializing in medicine, heart failure, and cardiovascular pharmacotherapy.

ORCID

Publications per year

1983–2021

29

Publications

29

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study

Richard N. Channick, G Simonneau, Olivier Sitbon et al. · The Lancet · 2001 · 1.5K citations

, , +13

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension

Olivier Sitbon, Marc Humbert, Hilario Nunès et al. · Journal of the American College of Cardiology · 2002 · 1.4K citations

, , +9

Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist

J H Korn, Maureen D. Mayes, M Matucci Cerinic et al. · Arthritis & Rheumatism · 2004 · 726 citations

, , +12

Effects of the oral endothelin-receptorantagonist bosentan on echocardiographicand doppler measures in patients with pulmonary arterial hypertension

Nazzareno Galiè, Alan L. Hinderliter, Adam Torbicki et al. · Journal of the American College of Cardiology · 2003 · 380 citations

, , +16

Effects of Tezosentan on Symptoms and Clinical Outcomes in Patients With Acute Heart Failure

John J.V. McMurray, John R. Teerlink, Gad Cotter et al. · JAMA · 2007 · 359 citations

, , +17

1–5 of 29